WASHINGTON — The Consumer Healthcare Products Association (CHPA), the national trade association representing leading manufacturers in the personal healthcare products industry, released the results of research showing that over-the-counter (O-T-C) medicine supplemental benefits programs offered by Medicare Advantage (MA) plans do not only help enrollees, they also benefit health plans. The new CHPA report, “Using
WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement from Marcia Howard, vice president, Scientific and Regulatory Affairs, upon the U.S. Food and Drug Administration (FDA) issuance of a Proposed Rule and Draft Guidance for establishing a regulatory category for over-the-counter (OTC) hearing aids: “CHPA applauds FDA for issuing this long-awaited proposed rule which
WASHINGTON – The Consumer Healthcare Products Association (CHPA) issued the following statement from Carlos Gutiérrez, vice president of government affairs, upon California Governor Gavin Newsom’s signature of AB 45, legalizing cannabidiol (CBD) in dietary supplements, food, and cosmetics. “CHPA thanks Governor Newsom for signing AB 45 into law. There is strong consumer and commercial interest in
WASHINGTON – The Consumer Healthcare Products Association (CHPA) today announced the appointment of Douglas “Duffy” MacKay as senior vice president, Dietary Supplements. MacKay is a highly-respected industry veteran with over two decades of commercial and non-profit experience in nutrition research, dietary supplement regulation, policy development, and association leadership. He will lead CHPA’s cross-functional dietary supplements
WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement in conjunction with the launch of The Global Self-Care Federation’s Self-Care Readiness Index (SCRI): “CHPA applauds The Global Self-Care Federation (GSCF) for the release of its new, pioneering report on self-care: The Self-Care Readiness Index (SCRI). Developed with the support of, and in partnership with, the World
WASHINGTON – Recently, the Consumer Healthcare Products Association (CHPA) hosted its Regulatory, Scientific and Quality (RSQ) Conference. The annual event showcased the increased conversation around prescription-to-nonprescription (Rx-to-OTC) switch among regulators, industry experts, and other stakeholders. It comes on the heels of a new study that points to the healthcare system savings from switch. OTC medicines provide
WASHINGTON – The Consumer Healthcare Products Association’s (CHPA) 2021 Regulatory, Scientific, and Quality (RSQ) Conference, held virtually last week, included a dietary supplement track with panels on emerging trends and issues for the category. The conference featured record participation from the U.S. Food and Drug Administration (FDA), including Acting Commissioner Dr. Janet Woodcock and Acting
WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement from Scott Melville, president and CEO, upon the introduction of H.R. 5214, the Dietary Supplements Access Act, by Representatives John Curtis (R, Utah) and Josh Gottheimer (D, N.J.): “CHPA applauds Representatives Curtis and Gottheimer for introducing bipartisan legislation that would make dietary supplements
WASHINGTON — The Consumer Healthcare Products Association (CHPA) today announced the finalists for the U.S. Self-Care Marketing Awards. With more than 50 entries received, a judging panel of nine independent experts narrowed the field to 21 finalists who will be honored at the foundation’s virtual annual gala on November 17 where the grand prize winner
WASHINGTON — The Consumer Healthcare Products Association (CHPA) will hold its 2021 Regulatory, Scientific & Quality (RSQ) Conference virtually Thursday, September 9, through Friday, September 10. CHPA’s annual event brings together an array of highly respected experts to discuss timely regulatory, scientific, legal, and product quality topics affecting the consumer healthcare products industry. After a year of
WASHINGTON — To combat teen abuse of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM), Ohio Governor Mike DeWine today signed into law HB 9, prohibiting the sale of DXM-containing products to minors without a prescription. The law will take effect on September 29, 2021. Ohio’s new law comes on the heels of the
NEW HOPE – The Consumer Healthcare Products Association (CHPA) today announced the election of Michelle Wang Goodridge as the new Chair of the CHPA board of directors. Goodridge was elected on June 16th, along with six new board members, at CHPA’s annual membership meeting held during the association’s new Self-Care Leadership Summit. Goodridge, a standing
WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement from Scott Melville, president and CEO, in response to the announcement that Patrizia Cavazzoni will succeed Janet Woodcock as the permanent director of the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research: “CHPA congratulates Patrizia Cavazzoni on her recent
WASHINGTON — The Senate on Thursday confirmed California Attorney General Xavier Becerra as President Joe Biden’s health secretary, filling a key position in the administration’s COVID-19 response and its major push to lower drug costs, expand insurance coverage, and eliminate racial disparities in medical care. The 50-49 vote makes the 63-year-old Becerra the first Latino
